Harpoon Therapeutics, Inc. HARP
Set alert
23.01 +23.01 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 865.08M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -5.09
- Beta
- 2.10
- Short ratio
- 0.37
- Inst. own
- 82.85%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 25, 2024
- 50-d avg
- 21.62
- 200-d avg
- 11.15
- 1y target
- 24.79
Analyst view
Consensus: buy
Buy
Price target (mean) 24.79 +7.7% upside
Now 23.01
- Target (low)
- 23.00
- Target (mean)
- 24.79
- Target (high)
- 27.00
Recommendation trend
- 1 month ago 9
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.50 | -0.74 – -0.03 | -5.50 | +90.9% | 7.67M | +87.6% | 3 |
| Next quarter | -0.90 | -0.90 – -0.90 | -3.10 | +71.0% | 12.50M | +45.6% | 1 |
| Current year | -1.20 | -1.63 – -0.21 | -20.40 | +94.1% | 39.96M | +25.2% | 4 |
| Next year | -4.52 | -10.00 – -0.03 | -1.20 | -276.7% | 31.08M | -22.2% | 4 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 17, 2023 | Citigroup | Maintained | Buy | Buy |
| Sep 13, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Sep 13, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |